Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study

Although further studies are needed to improve our understanding of seronegative NMOSD, our findings underscore the importance of aggressive treatment with high-efficacy immunotherapies in both NMOSD subtypes, regardless of serostatus.

Authors

Institutions

Publication Details

Journal
Journal of Neurology Neurosurgery & Psychiatry
Published
2024-09-04
DOI
https://doi.org/10.1136/jnnp-2024-334090
Citations
11
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
4.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study

Sifat Sharmin, José Luis Sánchez-Menoyo, Guy Laureys, Yi Chao Foong et al.
11 citations
Journal of Neurology Neurosurgery & Psychiatry
Multiple Sclerosis Research Studies
4.67
article

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study

Sifat Sharmin, José Luis Sánchez-Menoyo, Guy Laureys, Yi Chao Foong, Tomáš Kalinčík, Helmut Butzkueven, Mastura Monif, Anneke van der Walt, Saif Huda, Raed Alroughani, Pamela McCombe, Petra Nytrová, Wei Zhen Yeh, Samia Joseph Khoury, Matteo Foschi, Aysun Soysal, Recai Türkoğlu, Barbara Willekens, Francesco Patti, Abdullah Rashid Al-Asmi, Pakeeran Siriratnam, Ayşe Altıntaş, Paul G. Sanfilippo, Tünde Csépány, Vilija Jokubaitis, Serkan Özakbaş, Andrea Surcinelli, Chao Zhu, Masoud Etemadifar, Bassem Yamout, Magdolna Simó, Jeanette Lechner Scott
article en
11 citations

Abstract

Although further studies are needed to improve our understanding of seronegative NMOSD, our findings underscore the importance of aggressive treatment with high-efficacy immunotherapies in both NMOSD subtypes, regardless of serostatus.

Journal of Neurology Neurosurgery & PsychiatryVol. 96(4)
Semmelweis University (HU), Isfahan University of Medical Sciences (IR), Abu Dhabi University (AE), The Royal Melbourne Hospital (AU), Izmir University (TR), University of Debrecen (HU), Koç University (TR), University of Liverpool (GB), University of Antwerp (BE), İzmir University of Economics (TR), The University of Queensland (AU), The University of Melbourne (AU), Charles University (CZ), University of L'Aquila (IT), Islamic Azad University, Isfahan (IR), Royal Brisbane and Women's Hospital (AU), John Hunter Hospital (AU), Ghent University Hospital (BE), Walton Centre (GB), Royal Hobart Hospital (AU), Amiri Hospital (KW), University of Catania (IT), Bakırköy Psychiatric Hospital (TR), Hunter Medical Research Institute (AU), BioCruces Health research Institute (ES), Ospedale "Santa Maria delle Croci" di Ravenna (IT), Antwerp University Hospital (BE), American University of Beirut Medical Center (LB), Hospital de Galdakao (ES), Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (TR), Universitair Ziekenhuis Brussel (BE), Policlinico Universitario di Catania (IT), Sultan Qaboos University Hospital (OM), Hunter New England Local Health District (AU), Alfred Health (AU), Sultan Qaboos University (OM), Monash University (AU), American University of Beirut (LB)
Good health and well-being
Openalex Percentile: Top 5%
Multiple Sclerosis Research Studies
4.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.